We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
LSI Industries
LYTS
$834M
| $473K | 0.01% |
+27,828
| New | +$447K |
|
|
AAT
1227
American Assets Trust
AAT
$1.46B
| $471K | 0.01% |
23,839
-2,713
| -10% | -$52.8K |
|
1228
Financial Institutions
FISI
$812M
| $470K | 0.01% |
+18,302
| New | +$457K |
|
|
SLNO
1229
DELISTED
Soleno Therapeutics
SLNO
| $469K | 0.01% |
5,594
-34,831
| -86% | -$2.61M |
|
1230
Orthofix Medical
OFIX
$492M
| $467K | 0.01% |
+41,844
| New | +$518K |
|
1231
Viatris
VTRS
$20.8B
| $464K | 0.01% |
52,009
-21,282
| -29% | -$180K |
|
|
PINC
1232
DELISTED
Premier
PINC
| $464K | 0.01% |
+21,146
| New | +$455K |
|
|
NXRT
1233
NexPoint Residential Trust
NXRT
$689M
| $462K | 0.01% |
+13,864
| New | +$491K |
|
1234
Grupo Aeroportuario del Pacifico
PAC
$12.9B
| $455K | 0.01% |
+1,981
| New | +$423K |
|
1235
RenaissanceRe
RNR
$13.8B
| $454K | 0.01% |
+1,871
| New | +$453K |
|
|
FPI
1236
Farmland Partners
FPI
$415M
| $454K | 0.01% |
+39,420
| New | +$422K |
|
1237
Delek US
DK
$3.98B
| $454K | 0.01% |
+21,414
| New | +$360K |
|
|
TPC
1238
Tutor Perini Cor
TPC
$4.03B
| $452K | 0.01% |
+9,667
| New | +$308K |
|
1239
Theravance Biopharma
TBPH
$873M
| $452K | 0.01% |
+40,943
| New | +$398K |
|
|
VPU
1240
Vanguard Utilities ETF
VPU
$8.56B
| $450K | 0.01% |
+2,551
| New | +$440K |
|
1241
Invesco S&P MidCap Quality ETF
XMHQ
$5.44B
| $448K | 0.01% |
+4,564
| New | +$431K |
|
1242
Northrim BanCorp
NRIM
$593M
| $445K | 0.01% |
+19,088
| New | +$397K |
|
|
ECHO
1243
EchoStar
ECHO
$24.3B
| $445K | 0.01% |
16,056
-22,604
| -58% | -$497K |
|
1244
Grupo Cibest SA
CIB
$21.2B
| $445K | 0.01% |
+9,624
| New | +$400K |
|
1245
Leidos
LDOS
$14.4B
| $442K | 0.01% |
+2,800
| New | +$414K |
|
1246
NextNav
NN
$1.79B
| $441K | 0.01% |
+29,002
| New | +$372K |
|
1247
Pennant Group
PNTG
$1.43B
| $437K | 0.01% |
+14,650
| New | +$402K |
|
1248
Lionsgate Studios
LION
$3.89B
| $434K | 0.01% |
+74,738
| New | +$500K |
|
1249
Watsco Inc
WSO
$13.2B
| $434K | 0.01% |
983
+424
| +76% | +$197K |
|
1250
Sable Offshore Corp
SOC
$836M
| $433K | 0.01% |
+19,704
| New | +$458K |
|
Similar funds
HSA
O
LFG
JIM
CTC
NL
BPWM
VT
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.